Background Whether probiotics are beneficial at all stages of treatment in inflammatory
bowel disease or superior to placebo remains controversial. Methods Two reviewers …

This was a pilot study aiming to evaluate the effects of probiotics as adjunctive treatment for
ulcerative colitis (UC). Twenty‐five active patients with UC were assigned to the probiotic (n …

The gut microbiome in the inflammatory bowel disease, ulcerative colitis (UC), is different to
that of healthy controls. Patients with UC have relative reductions in abundance of …

The incidence, prevalence, and cost of care associated with diagnosis and management of
inflammatory bowel disease are on the rise. The role of gut microbiota in the causation of …

Context Crohn's disease and ulcerative colitis result in similar gastrointestinal (GI)
symptoms, including pain, diarrhea, stools with mucus or blood, and ulceration or tissue …

Background Ulcerative colitis is a chronic relapsing disease characterised by diffuse
mucosal inflammation limited to the colon. Current maintenance treatments have multiple …

Human subjects and their enteric microbiota have evolved together to reach a state of
mutual tolerance. Mounting evidence from both animal models and human studies suggests …

A complex set of interactions between the human genes encoding innate protective
functions and immune defenses and the environment of the intestinal mucosa with its …

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the
gastrointestinal tract affecting millions of patients worldwide. The gut microbiome partly …

Background: Many preclinical studies have demonstrated the effectiveness of genetically
modified probiotics (gm probiotics) in animal models of inflammatory bowel disease (IBD) …